Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 220

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

ILC2-modulated T cell–to-MDSC balance is associated with bladder cancer recurrence

Open access
Chevalier, Mathieu F., Trabanelli, Sara, Racle, Julien, Salomé, Bérengère, Cesson, Valérie, Gharbi, Dalila, Bohner, Perrine, Domingos-Pereira, Sonia, Dartiguenave, Florence, Fritschi, Anne-Sophie, Speiser, Daniel E., Rentsch, Cyrill A., Gfeller, David, Jichlinski, Patrice, Nardelli-Haefliger, Denise, Jandus, Camilla, Derré, Laurent · 2017 · Journal of Clinical Investigation

Abstract

Non-muscle-invasive bladder cancer (NMIBC) is a highly recurrent tumor despite intravesical immunotherapy instillation with the bacillus Calmette-Guérin (BCG) vaccine. In a prospective longitudinal study, we took advantage of BCG instillations, which increase local immune infiltration, to characterize immune cell populations in the urine of patients with NMIBC as a surrogate for the bladder tumor microenvironment. We observed an infiltration of neutrophils, T cells, monocytic myeloid-derived suppressor cells (M-MDSCs), and group 2 innate lymphoid cells (ILC2). Notably, patients with a T cell-to-MDSC ratio of less than 1 showed dramatically lower recurrence-free survival than did patients with a ratio of greater than 1. Analysis of early and later time points indicated that this patient dichotomy existed prior to BCG treatment. ILC2 frequency was associated with detectable IL-13 in the urine and correlated with the level of recruited M-MDSCs, which highly expressed IL-13 receptor α1. In vitro, ILC2 were increased and potently expressed IL-13 in the presence of BCG or tumor cells. IL-13 induced the preferential recruitment and suppressive function of monocytes. Thus, the T cell-to-MDSC balance, associated with a skewing toward type 2 immunity, may predict bladder tumor recurrence and influence the mortality of patients with muscle-invasive cancer. Moreover, these results underline the ILC2/IL-13 axis as a targetable pathway to curtail the M-MDSC compartment and improve bladder cancer treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci89717

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 220

Metadata

Authors
Chevalier, M. F., Trabanelli, S., Racle, J., Salomé, B., Cesson, V., Gharbi, D., Bohner, P., Domingos-Pereira, S., Dartiguenave, F., Fritschi, A.-S., Speiser, D. E., Rentsch, C. A., Gfeller, D., Jichlinski, P., Nardelli-Haefliger, D., Jandus, C., & Derré, L.
Venue
Journal of Clinical Investigation
Published
2017-06-26
Volume
127
Issue
8
Pages
2916-2929
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W2647469809
Cited by
220
References
7
FWCI
7.85
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ILC2-modulated T cell–to-MDSC balance is associated with bladder cancer recurrence. https://app.cochat.ai/papers/10.1172/jci89717
The paper
Chevalier, M. F., Trabanelli, S., Racle, J., Salomé, B., Cesson, V., Gharbi, D., Bohner, P., Domingos-Pereira, S., Dartiguenave, F., Fritschi, A.-S., Speiser, D. E., Rentsch, C. A., Gfeller, D., Jichlinski, P., Nardelli-Haefliger, D., Jandus, C., & Derré, L. (2017). ILC2-modulated T cell–to-MDSC balance is associated with bladder cancer recurrence. Journal of Clinical Investigation. https://doi.org/10.1172/jci89717

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.